Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Luisa Moro

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Recenti Progressi in Medicina|January 30, 2020
[Prescribing appropriateness, use and consumption of antibiotics in Italy. An extract from the National Report 2018.]Agnese Cangini, Carlo Gagliotti, Filomena Fortinguerra, et al.
Infection Control and Hospital Epidemiology|February 12, 2020
Point prevalence data on antimicrobial usage in Italian acute-care hospitals: Evaluation and comparison of results from two national surveys (2011-2016)Costanza Vicentini, Francesca Quattrocolo, Angelo D'Ambrosio, et al.
American Journal of Infection Control|September 3, 2014
Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control studyCarlo Gagliotti, Stefano Giordani, Vincenzo Ciccarese, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 7, 2019
Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017Simone Iacchini, Michela Sabbatucci, Carlo Gagliotti, et al.
Pharmacoepidemiology and Drug Safety|July 11, 2024
Use of Azithromycin Attributable to Acute SARS-CoV-2 InfectionCarlo Gagliotti, Federico Banchelli, Rossella Buttazzi, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2016
Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineageViola Conte, Monica Monaco, Tommaso Giani, et al.
British Journal of Clinical Pharmacology|July 10, 2020
Monitoring the community use of antibiotics in Italy within the National Action Plan on antimicrobial resistanceAgnese Cangini, Filomena Fortinguerra, Aurora Di Filippo, et al.
Scientific Reports|February 12, 2021
Use of multiple metrics to assess antibiotic use in Italian children's hospitalsCarmen D'Amore, Marta Luisa Ciofi Degli Atti, Carla Zotti, et al.
Archives of Public Health = Archives Belges De Sante Publique|March 24, 2025
Short-term acute outcomes by clinical and socioeconomic characteristics in adults with SARS-CoV-2: a population-based cohort study focused on the first two years of the COVID-19 pandemicAlice Corsaro, Federico Banchelli, Rossella Buttazzi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 22, 2018
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017Enrico Ricchizzi, Katrien Latour, Tommi Kärki, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Recenti Progressi in Medicina|January 30, 2020
[Prescribing appropriateness, use and consumption of antibiotics in Italy. An extract from the National Report 2018.]Agnese Cangini, Carlo Gagliotti, Filomena Fortinguerra, et al.
Infection Control and Hospital Epidemiology|February 12, 2020
Point prevalence data on antimicrobial usage in Italian acute-care hospitals: Evaluation and comparison of results from two national surveys (2011-2016)Costanza Vicentini, Francesca Quattrocolo, Angelo D'Ambrosio, et al.
American Journal of Infection Control|September 3, 2014
Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control studyCarlo Gagliotti, Stefano Giordani, Vincenzo Ciccarese, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 7, 2019
Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017Simone Iacchini, Michela Sabbatucci, Carlo Gagliotti, et al.
Pharmacoepidemiology and Drug Safety|July 11, 2024
Use of Azithromycin Attributable to Acute SARS-CoV-2 InfectionCarlo Gagliotti, Federico Banchelli, Rossella Buttazzi, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2016
Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineageViola Conte, Monica Monaco, Tommaso Giani, et al.
British Journal of Clinical Pharmacology|July 10, 2020
Monitoring the community use of antibiotics in Italy within the National Action Plan on antimicrobial resistanceAgnese Cangini, Filomena Fortinguerra, Aurora Di Filippo, et al.
Scientific Reports|February 12, 2021
Use of multiple metrics to assess antibiotic use in Italian children's hospitalsCarmen D'Amore, Marta Luisa Ciofi Degli Atti, Carla Zotti, et al.
Archives of Public Health = Archives Belges De Sante Publique|March 24, 2025
Short-term acute outcomes by clinical and socioeconomic characteristics in adults with SARS-CoV-2: a population-based cohort study focused on the first two years of the COVID-19 pandemicAlice Corsaro, Federico Banchelli, Rossella Buttazzi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 22, 2018
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017Enrico Ricchizzi, Katrien Latour, Tommi Kärki, et al.
Pageof 9